Alkermes to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

Alkermes (Nasdaq: ALKS) said management will participate in two investor conferences in November 2025: the Stifel 2025 Healthcare Conference on Nov. 13, 2025 at 2:40 p.m. ET and the Jefferies Global Healthcare Conference in London on Nov. 19, 2025 at 11:30 a.m. ET.

Both events will be webcast live and the webcasts will be available under the Investors tab at www.alkermes.com and archived for 14 days.

Argus Nov 7 session

+3.82% close to close 0.7x rel. volume Open Argus

Details

News Market Reaction – ALKS

On Nov 7, the first trading day after this news, ALKS closed 3.82% above the previous close.

Data tracked by StockTitan Argus for the Nov 7 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DUBLIN, Nov. 6, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences.

Stifel 2025 Healthcare Conference
Date/Time: Thursday, Nov. 13, 2025 at 2:40 p.m. ET (7:40 p.m. GMT)

Jefferies Global Healthcare Conference in London
Date/Time: Wednesday, Nov. 19, 2025 at 11:30 a.m. ET (4:30 p.m. GMT)

The live webcasts may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc
Alkermes plc (Nasdaq: ALKS), a mid-cap growth and value equity, is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathic hypersomnia. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-two-upcoming-investor-conferences-302607396.html

SOURCE Alkermes plc

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Alkermes (ALKS) present at the Stifel 2025 Healthcare Conference?

Alkermes will present on Nov. 13, 2025 at 2:40 p.m. ET.

What time is Alkermes (ALKS) scheduled for the Jefferies Global Healthcare Conference in London?

The Alkermes presentation is scheduled for Nov. 19, 2025 at 11:30 a.m. ET.

How can investors watch Alkermes (ALKS) webcasts for the November 2025 conferences?

Live webcasts are available under the Investors tab at www.alkermes.com.

How long will Alkermes (ALKS) conference webcasts be archived after the live events?

The webcasts will be archived and available for 14 days after the live event.

Will Alkermes (ALKS) provide on-demand access for both November 2025 conference presentations?

Yes; both presentations will be webcast live and archived for on-demand access for 14 days.

Where is Alkermes (ALKS) headquartered and what areas does its portfolio target?

Alkermes is headquartered in Ireland and has products and a pipeline focused on neuroscience disorders including treatment areas such as alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder, narcolepsy, and idiopathic hypersomnia.